Transcatheter aortic valve replacement: potential use in lower-risk aortic stenosis

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Surgical Innovation

Background:

• Transcatheter aortic valve implantation (TAVI) is increasingly used in low-risk patients.
• Low clinical risk does not always equate to low procedural risk for TAVI.

Purpose of the Study:

• To evaluate the suitability of TAVI for low-risk patients compared to surgical aortic valve replacement (SAVR).
• To identify specific patient features impacting TAVI procedural outcomes.
• To assess the need for longer follow-up regarding valve durability and coronary re-access.

Main Methods:

• Analysis of initial trials comparing TAVI and SAVR in low-risk populations.
• Review of risk score calculators and their limitations for TAVI.
• Identification of anatomical and procedural factors influencing TAVI outcomes.

Main Results:

• Initial trials indicate TAVI is non-inferior to SAVR in low-risk patients.
• Current risk scores do not fully capture TAVI-specific procedural risks.
• Factors like bicuspid valves and calcification can affect TAVI outcomes.

Conclusions:

• While TAVI and SAVR show similar results in low-risk groups, technical and procedural gaps persist.
• Addressing these limitations is crucial for TAVI to match surgical outcomes.
• Optimal, durable TAVI results are expected in healthy, low-risk individuals.